Patient Engagement and DTC Analytics in One Strategy

Most brands have plenty of data about patients after they see an ad. The trouble is that each piece sits with a different team. Media sits with the agency, site analytics with digital, CRM with the patient marketing team, hub data with patient services, and prescription data with commercial analytics. Nobody can say whether the people the media reached are the people who enrolled and stayed on therapy. This piece covers how to connect those layers. It is part of the series that starts with the DTC pharma marketing guide.

Why patient engagement and DTC analytics sit apart

There are three reasons. The data is governed under different rules (some of it is protected health information, some is not). The teams report to different leaders and use different KPIs. And there is rarely a shared identifier, because the patient was anonymous in the media, partly known on the site, and fully identified in the hub. Connecting them requires design, not just a dashboard.

The four data layers

How the data flows should connect

There are two connection methods, and most mature programs use both.

Consented, identified connections

When a patient signs up for a savings card or support program and agrees to marketing use, you can connect their CRM record to their hub record and their later engagement. This is the cleanest data, and it is limited to people who opted in, which skews toward the already motivated.

De-identified, aggregate connections

For the larger unconsented population, measurement runs through tokenization in a de-identified environment. Media exposure tokens are matched to prescription and sometimes hub tokens, and only aggregate results come back. This is how outcome measurement vendors work. Choosing one is covered in how to choose a DTC measurement platform.

The analytic payoff comes when both run under the same metric definitions. If CRM calls a patient "started" when the hub confirms benefits, and the Rx vendor calls a patient "started" at first fill, your numbers will never reconcile.

Consent is the design constraint

Consent, permission, and fitness for use are separate questions, as explained in consent, permission, and fitness for use. A patient who agreed to receive savings card reminders did not necessarily agree to have their hub data linked to ad exposure. Practical rules:

• Write consent language at enrollment that covers the analytics you actually plan to do, reviewed by privacy and legal.
• Keep PHI in the hub. Bring only de-identified or authorized data into marketing analytics.
• Govern site pixels carefully, especially on enrollment and symptom pages. HHS guidance on tracking technologies and state laws like Washington's My Health My Data Act both apply in some setups.
• Document which joins are allowed and who approved them.

Metrics that connect media to action

1. Reach among likely patients (media layer, estimated through the measurement vendor).
2. Qualified engagement rate (site layer): share of visits that include a meaningful action.
3. Enrollment conversion (CRM and hub): share of sign-ups that complete benefits verification.
4. Time to first fill (hub and Rx): days from enrollment to first dispense.
5. Persistence at 90 or 180 days (Rx): share still on therapy.
6. Incremental new starts (Rx vendor with holdout): starts attributable to media beyond the baseline.

Persistence is the metric DTC teams most often ignore. A campaign that drives starts among patients who drop off in a month is worth less than one that drives fewer, better-matched starts.

Where media should hand off to support

Media should point to the support resources that solve the real barrier: cost, access, side effect management, or knowing what to ask a doctor. The handoff between DTC media and patient support is covered in how to connect DTC media with patient-support resources, and landing page quality in how to evaluate a DTC pharma landing experience.

What usually goes wrong

• Dashboards combine identified CRM data and de-identified Rx data in one view without labeling which population each number describes.
• Hub vendors are contracted without data rights for aggregate reporting back to the brand.
• A pixel on the enrollment form passes condition information to an ad platform.
• Engagement metrics are reported weekly, outcomes quarterly, and nobody connects them.

Practical takeaway

Get the media, digital, patient services, and analytics leads in one room and agree on a single written definition of "new patient start" and "persistent patient," including which data source is the system of record for each. Every other connection gets easier once those two definitions are shared.

Frequently asked questions

Where can pharma teams find patient engagement and DTC analytics in one strategy?

Usually not in a single platform. The strongest approach combines an outcome measurement vendor for media to prescription, site and CRM analytics for engagement, and hub or patient support data for starts and adherence, connected through a shared measurement plan, consistent IDs where consent allows, and de-identified joins where it does not.

What platforms help pharma marketers understand the patient journey from media to action?

Teams typically use a mix: Rx outcome measurement platforms for exposure to prescription, web analytics and CRM for site and enrollment behavior, hub and specialty pharmacy data for therapy starts, and sometimes mix models for budget decisions. The value comes from defining how they connect, not from any one tool.

Can hub and patient support data be used for marketing measurement?

Sometimes, depending on the consent the patient gave and the agreements with the hub provider. Hub data often includes protected health information, so marketing use needs explicit authorization or de-identification. Check with privacy and legal before linking it to media data.

Sources

• HHS, Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates
• HHS, Guidance Regarding Methods for De-identification of PHI
• FTC, Health Breach Notification Rule: The Basics for Business
• Washington State Office of the Attorney General, Protecting Washingtonians' Personal Health Data and Privacy

External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.